FDA raids Snapdeal premises for selling ‘drugs’

Maharashtra's Food and Drugs Administration (FDA) has raided the premises of e-commerce major Snapdeal.com for allegedly selling medicines, including prescription drugs. Meanwhile, the company has said it has delisted the drugs on its portal and is assisting the FDA in the investigation.

"...upon receiving the notice, we have delisted the products and provided all information to the FDA team. We shared the details of our fulfillment center as required by the FDA team. Upon their visit to the fulfillment center, they have not found any such product. We are assisting the FDA team in this investigation," a Snapdeal spokesperson said. FDA Commissioner Harshadeep Kamble said, "A team of FDA officers on Thursday raided the premises of Snapdeal in Mumbai.”